These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3334661)

  • 1. Leukemia and lymphoma.
    Freireich EJ
    Chemioterapia; 1987 Jun; 6(2 Suppl):677-9. PubMed ID: 3334661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intensive treatment and autologous bone marrow transplantation in cases of acute leukemia and lymphoma].
    Chapuis B; Helg C; Aapro M; Maurice P; Pipard G; Wyss M
    Schweiz Med Wochenschr; 1986 Aug; 116(34):1158-9. PubMed ID: 3532313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Achievements in the treatment of leukemia and lymphoma].
    Berchenal J
    Klin Med (Mosk); 1973 Jun; 51(6):15-20. PubMed ID: 4590258
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hematologic cancers in 1987. Chemotherapy and immunotherapy].
    Fillet G; Bury J; Beguin Y; Duvivier A; Hoyoux C; Bours V
    Rev Med Liege; 1987 May; 42(10):496-502. PubMed ID: 2441448
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular targeted treatment of hematological diseases with monoclonal antibodies and tyrosine kinase inhibitors. The Danish Society of Hematology].
    Geisler CH
    Ugeskr Laeger; 2002 Mar; 164(12):1655. PubMed ID: 11924277
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: Leukaemia-lymphoma: diagnosis and practical management.
    Med J Aust; 1974 Jun; 1(25):977-8. PubMed ID: 4851522
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation.
    Blume KG; Long GD; Negrin RS; Chao NJ; Kusnierz-Glaz C; Amylon MD
    Bone Marrow Transplant; 1994; 14 Suppl 4():S9-10. PubMed ID: 7728133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effects of peripheral blood stem cell transplantation following combination chemotherapy using ranimustine, cytarabine, etoposide and cyclophosphamide for patients with hematological malignancies].
    Yamane T; Ohta T; Kou KR; Hashimoto S; Takekawa K; Hirai N; Tanaka K; Hasuike T; Hirai M; Ohta K
    Gan To Kagaku Ryoho; 1994 May; 21(6):903-6. PubMed ID: 7910450
    [No Abstract]   [Full Text] [Related]  

  • 9. Features suggesting curability in lymphoma and leukemia.
    Burchenal JH
    CA Cancer J Clin; 1973; 23(6):344-53. PubMed ID: 4203040
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aspects of molecular remission in hematology and oncology].
    Novik AA; Kamilova TA; Tsygan VN
    Vopr Onkol; 2001; 47(3):270-7. PubMed ID: 11544823
    [No Abstract]   [Full Text] [Related]  

  • 11. [Total body irradiation in hematology: clinical indications and prospects].
    Corvò R
    Recenti Prog Med; 1999 Nov; 90(11):601-4. PubMed ID: 10608150
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of tumor markers in the treatment of cancer: hematologic malignancy].
    Sampi K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3041-5. PubMed ID: 3674891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma.
    Grigg A; Bardy P; Byron K; Seymour JF; Szer J
    Bone Marrow Transplant; 1999 Jan; 23(2):107-10. PubMed ID: 10197793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.
    Maruyama D; Fukuda T; Kato R; Yamasaki S; Usui E; Morita-Hoshi Y; Kim SW; Mori S; Heike Y; Makimoto A; Tajima K; Tanosaki R; Tobinai K; Takaue Y
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):932-41. PubMed ID: 17640597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of human lymphoblast interferon in adult T-cell leukemia and non-Hodgkin's lymphoma].
    Kamihira S; Soda H; Kinoshita K; Ichimaru M
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2188-93. PubMed ID: 6605114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to current status reports on leukemia and lymphoma therapy.
    Henderson ES
    Semin Hematol; 1972 Apr; 9(2):137-40. PubMed ID: 5019000
    [No Abstract]   [Full Text] [Related]  

  • 17. The single cell gel electrophoresis: a potential tool for DNA analysis of the patients with hematological malignancies.
    Bacová G; Gábelová A; Babusíková O; Slamenová D
    Neoplasma; 1998; 45(6):349-59. PubMed ID: 10210107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of leukemia and lymphoma.
    WALLERSTEIN RO; AGGELER PM; HOAG MS
    J Am Med Womens Assoc; 1957 Dec; 12(12):417-22. PubMed ID: 13491364
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic complications of induction therapy for leukemia and lymphoma.
    Cohen DG
    Cancer Nurs; 1983 Aug; 6(4):307-10. PubMed ID: 6554111
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy in lymphoma & leukemia].
    SILVA MS
    Rev Paul Med; 1957 Mar; 50(3):190-5. PubMed ID: 13442166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.